Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Culture-Negative Infective Endocarditis due to <i>Neisseria bacilliformis</i>: A Rare Case With Multisystem Embolization and Diagnostic Utility of Microbial Cell-Free DNA Testing.

Clinical case reports·2026
Same author

Evolutionary implications of <i>NOTCH2NLC</i> mutations: brain structural changes in neuronal intranuclear inclusion disease revealed by comprehensive morphometry.

Brain communications·2026
Same author

An updated catalog of earthquakes with M ≥ 4.7 from 2300 BC to 2024 AD for the China's new seismic zonation map.

Scientific data·2026
Same author

Age-Associated Variations in Complete Blood Cell Count Parameters and Derived Indices Among Community-Dwelling Chinese Older Adults.

Journal of clinical laboratory analysis·2026
Same author

CDK4 Mediates Cisplatin Resistance in Renal Cell Carcinoma (RCC) Cells by Regulating the ASH1L-CTR1 Axis.

Oncology research·2026
Same author

High-performance 2D MoTe<sub>2</sub>-based photodetectors with superior Vis-NIR detection capability.

RSC advances·2026

Related Experiment Video

Updated: Dec 26, 2025

Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli
13:10

Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli

Published on: September 25, 2016

10.2K

Formulation and Characterization of Antithrombin Perfluorocarbon Nanoparticles.

Alexander J Wilson1, Qingyu Zhou2, Ian Vargas1

  • 1The USF Health Heart Institute, University of South Florida, Tampa, FL, USA.

Methods in Molecular Biology (Clifton, N.J.)
|March 11, 2020
PubMed
Summary
This summary is machine-generated.

Researchers developed novel antithrombin nanoparticles using bivalirudin and PPACK. These nanoparticles offer targeted anticoagulation, potentially reducing bleeding risks associated with thrombosis treatments.

Keywords:
AnticoagulationBivalirudinPPACKPerfluorocarbon nanoparticlesThrombin

More Related Videos

Formulation and Acoustic Modulation of Optically Vaporized Perfluorocarbon Nanodroplets
07:44

Formulation and Acoustic Modulation of Optically Vaporized Perfluorocarbon Nanodroplets

Published on: July 16, 2021

2.5K
Flash NanoPrecipitation for the Encapsulation of Hydrophobic and Hydrophilic Compounds in Polymeric Nanoparticles
10:12

Flash NanoPrecipitation for the Encapsulation of Hydrophobic and Hydrophilic Compounds in Polymeric Nanoparticles

Published on: January 7, 2019

23.3K

Related Experiment Videos

Last Updated: Dec 26, 2025

Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli
13:10

Combined Near-infrared Fluorescent Imaging and Micro-computed Tomography for Directly Visualizing Cerebral Thromboemboli

Published on: September 25, 2016

10.2K
Formulation and Acoustic Modulation of Optically Vaporized Perfluorocarbon Nanodroplets
07:44

Formulation and Acoustic Modulation of Optically Vaporized Perfluorocarbon Nanodroplets

Published on: July 16, 2021

2.5K
Flash NanoPrecipitation for the Encapsulation of Hydrophobic and Hydrophilic Compounds in Polymeric Nanoparticles
10:12

Flash NanoPrecipitation for the Encapsulation of Hydrophobic and Hydrophilic Compounds in Polymeric Nanoparticles

Published on: January 7, 2019

23.3K

Area of Science:

  • Biochemistry
  • Nanotechnology
  • Pharmacology

Background:

  • Thrombin is a key protein in blood clotting, crucial for thrombosis development.
  • Antithrombin nanoparticles offer a promising strategy for localized anticoagulation, minimizing systemic bleeding risks.

Purpose of the Study:

  • To describe the synthesis and characterization of bivalirudin and D-phenylalanyl-L-prolyl-L-arginyl-chloromethyl ketone (PPACK) nanoparticles.
  • To evaluate the potential of these nanoparticles for site-specific anticoagulation.

Main Methods:

  • Nanoparticle synthesis involving bivalirudin and PPACK.
  • Characterization techniques including particle size analysis and zeta potential measurement.
  • Quantification of drug loading for PPACK and bivalirudin within nanoparticles.

Main Results:

  • Successful fabrication of bivalirudin and PPACK nanoparticles.
  • Detailed characterization data regarding particle size, zeta potential, and drug loading efficiency.
  • Established methods for nanoparticle quality control.

Conclusions:

  • Bivalirudin and PPACK nanoparticles can be successfully synthesized and characterized.
  • These nanoparticles represent a viable platform for targeted anticoagulation therapies.
  • Further research is warranted to explore their in vivo efficacy and safety profile.